{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:39:38Z","timestamp":1780648778520,"version":"3.54.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Trust is key in AI for regulatory science, but its definition is debated. If AI models use different features yet perform similarly, which should be trusted? If scientific theories must be testable, how critical is explainability? At the Global Summit on Regulatory Science (GSRS24), regulators agreed that successful AI adoption requires ongoing dialogue, adaptability, and AI-trained personnel to harness its potential for regulatory responsibilities in the evolving 21st-century landscape.<\/jats:p>","DOI":"10.1038\/s41746-025-01596-0","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:10:23Z","timestamp":1744287023000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Is regulatory science ready for artificial intelligence?"],"prefix":"10.1038","volume":"8","author":[{"given":"Thomas","family":"Hartung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weida","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Califf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"1596_CR1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1126\/science.1204432","volume":"331","author":"MA Hamburg","year":"2011","unstructured":"Hamburg, M. A. Advancing regulatory science. Science 331, 987 (2011).","journal-title":"Science"},{"key":"1596_CR2","unstructured":"Global Coalition for Regulatory Science Research, https:\/\/gcrsr.net\/."},{"key":"1596_CR3","unstructured":"The 14th Global Summit on Regulatory Science (GSRS24) Conference, https:\/\/gcrsr.net\/2024-gsrs\/."},{"key":"1596_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/jama.2024.21451","volume":"333","author":"HJ Warraich","year":"2025","unstructured":"Warraich, H. J., Tazbaz, T. & Califf, R. M. FDA perspective on the regulation of artificial intelligence in health care and biomedicine. JAMA 333, 241\u2013247 (2025).","journal-title":"JAMA"},{"key":"1596_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00204-023-03666-2","volume":"98","author":"N Kleinstreuer","year":"2024","unstructured":"Kleinstreuer, N. & Hartung, T. Artificial intelligence (AI)-it\u2019s the end of the tox as we know it (and I feel fine). Arch. Toxicol. 98, 735\u2013754 (2024).","journal-title":"Arch. Toxicol."},{"key":"1596_CR6","unstructured":"GCRSR Interagency LLMs Taskforce, https:\/\/gcrsr.net\/llms-task-force\/."},{"key":"1596_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.103916","volume":"29","author":"W Tong","year":"2024","unstructured":"Tong, W., Renaudin, M. & Taskforce, G. I. L. Context is everything in regulatory application of large language models (LLMs). Drug Discov. Today 29, 103916 (2024).","journal-title":"Drug Discov. Today"},{"key":"1596_CR8","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.1038\/s41586-020-2766-y","volume":"586","author":"B Haibe-Kains","year":"2020","unstructured":"Haibe-Kains, B. et al. Transparency and reproducibility in artificial intelligence. Nature 586, E14\u2013E16 (2020).","journal-title":"Nature"},{"key":"1596_CR9","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.1665","volume":"28","author":"L Shi","year":"2010","unstructured":"Shi, L. et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat. Biotechnol. 28, 827\u2013838 (2010).","journal-title":"Nat. Biotechnol."},{"key":"1596_CR10","doi-asserted-by":"publisher","unstructured":"Leptak, C. et al. What evidence do we need for biomarker qualification? Sci. Transl. Med. 9. https:\/\/doi.org\/10.1126\/scitranslmed.aal4599 (2017).","DOI":"10.1126\/scitranslmed.aal4599"},{"key":"1596_CR11","unstructured":"US FDA\u2019s Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program, https:\/\/www.fda.gov\/drugs\/drug-development-tool-ddt-qualification-programs\/innovative-science-and-technology-approaches-new-drugs-istand-pilot-program."},{"key":"1596_CR12","first-page":"3","volume":"42","author":"T Hartung","year":"2025","unstructured":"Hartung, T. & Kleinstreuer, N. Challenges and opportunities for validation of AI-based new approach methods. ALTEX 42, 3\u201321 (2025).","journal-title":"ALTEX"},{"key":"1596_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104058","volume":"29","author":"W Tong","year":"2024","unstructured":"Tong, W. & Baran, S. W. 50 shades of AI in regulatory science. Drug Discov. Today 29, 104058 (2024).","journal-title":"Drug Discov. Today"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01596-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01596-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01596-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T12:10:29Z","timestamp":1744287029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01596-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1596"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01596-0","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}